Advanced search

Steven A.
Bernstein is Vice President of International Market Development for The PMI Group, Inc. Previously, Mr. Bernstein was a Director of Promontory Financial Group LLC.
He held various senior positions at the US Department of the Treasury.
Mr. Bernstein held various positions at Ginnie Mae, most recently as Chief Economist.
He received a Bachelor's degree in Management Science and Political Science and a Master's degree in Political Science from the University of California.

Mr. Steve Bernstein is Vice President-Analytics at Deem, Inc. Mr. Bernstein was previously employed as a Director-Global Web Team by Avid Systems, Inc., a Director-Web Analytics by PayPal, Inc., a Manager-Marketing Research by Hewlett-Packard Co., Marketing Manager by Apple, Inc., Vice President-Analytics by MySpace, Inc., and Vice President-Enterprise Solutions by Applied Semantics, Inc. He received his undergraduate degree from the University of California, Berkeley and a graduate degree from Stanford University.

Steven L.
Bernstein is currently working as the CFO, Secretary, Treasurer & Controller at Frequency Electronics, Inc. He started this position in 2016.
Prior to his current job, he attended Queens College where he completed his undergraduate degree.

Steven E. Bernstein founded SBA Communications Corp. and SBA Communications Corp. Presently, Mr. Bernstein occupies the position of Chairman for SBA Communications Corp. Mr. Bernstein is also on the board of VISIONS and Manager at Shoppes of Winter Park LLC, Manager for Bernstein Realty LLC and Manager at Louisville Bernstein LLC. In the past Mr. Bernstein was Chairman of SBA Communications Corp. Steven E. Bernstein received an undergraduate degree from the University of Florida.

Steven A.
Bernstein is the founder of CrowdPharm LLC, which is founded in 2017, where he holds the title of Partner.
Currently, he is the President of Bernstein-Rein Advertising, Inc.

Steven Heston Bernstein has been a Director at Lawrence Stephens Ltd.
since 2004.

Steven H.
Bernstein is currently the Chief Medical Officer at 2seventy Bio, Inc. He previously worked as the Chairman of Immuno-Oncology Translational Research at Bristol Myers Squibb Co., a Professor of Medicine and Co-Director of Hematological at James P.
Wilmot Cancer Center, a Member of Lymphoma Working Group at SWOG, and the Chief Translational Officer at Turnstone Biologics Corp.
He received his undergraduate degree from Brandeis University and his doctorate from New York University School of Medicine.